NR4A1 and breast carcinoma: Another limitation of the study is the lack of information on hormone receptor status of the tumor; however, since 70–80% of breast cancers included in our study of postmenopausal women are likely to be hormone receptor positive, the results are largely representative of hormonally responsive breast cancers.40